Voyager Therapeutics, Inc. (VYGR)
NASDAQ: VYGR · Real-Time Price · USD
4.850
-0.150 (-3.00%)
At close: Mar 11, 2026, 4:00 PM EDT
4.976
+0.126 (2.60%)
After-hours: Mar 11, 2026, 7:10 PM EDT
Voyager Therapeutics Market Cap
Voyager Therapeutics has a market cap or net worth of $289.06 million as of March 11, 2026. Its market cap has increased by 29.04% in one year.
Market Cap
289.06M
Enterprise Value
123.86M
1-Year Change
29.04%
Ranking
Category
Stock Price
$4.85
Market Cap Chart
Since November 11, 2015, Voyager Therapeutics's market cap has decreased from $456.60M to $289.06M, a decrease of -36.69%. That is a compound annual growth rate of -4.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 10, 2026 | 298.00M | 36.38% |
| Dec 31, 2025 | 218.50M | -29.45% |
| Dec 31, 2024 | 309.70M | -16.59% |
| Dec 29, 2023 | 371.30M | 57.66% |
| Dec 30, 2022 | 235.50M | 128.86% |
| Dec 31, 2021 | 102.90M | -61.59% |
| Dec 31, 2020 | 267.90M | -48.20% |
| Dec 31, 2019 | 517.20M | 69.02% |
| Dec 31, 2018 | 306.00M | -31.60% |
| Dec 29, 2017 | 447.40M | 31.43% |
| Dec 30, 2016 | 340.40M | -41.89% |
| Dec 31, 2015 | 585.80M | 28.30% |
| Nov 11, 2015 | 456.60M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nuvectis Pharma | 240.54M |
| Cartesian Therapeutics | 234.55M |
| Protalix BioTherapeutics | 231.61M |
| Humacyte | 231.60M |
| Eledon Pharmaceuticals | 230.12M |
| Canton Strategic Holdings | 229.26M |
| Sol-Gel Technologies | 228.43M |
| Editas Medicine | 226.48M |